Conshohocken, Pennsylvania, United States, October 28, 2026
Suvoda, a clinical trial technology company, has announced significant enhancements to its Greenphire Travel platform, introducing expanded transportation options and improved patient travel management capabilities to help participants remain enrolled in clinical trials. Announced on October 28, 2026, the latest expansion aims to reduce the logistical challenges associated with travelling to clinical research sites and improve the overall patient experience. The updated platform integrates additional rideshare services, including Lyft, Uber Health and Bolt, while providing patients with greater control over their travel arrangements through the Suvoda App. The announcement addresses a major challenge in clinical research: patient recruitment, participation and retention. According to the company, travel remains one of the significant logistical barriers affecting clinical trial participation. A recent CISCRP study found that among participants who considered their clinical trial experience disruptive, 49% identified travel to the study clinic as a contributing factor. Through its latest improvements, Suvoda aims to simplify transportation coordination, reduce administrative responsibilities for clinical trial sites and help sponsors and contract research organisations (CROs) improve participant engagement.
Expanded Transportation Options Improve Patient Convenience
The latest Greenphire Travel release introduces expanded access to global rideshare and car transportation services, enabling eligible clinical trial participants to arrange transportation more conveniently. Through integrations with Lyft, Uber Health and Bolt, participants and clinical trial sites can access additional ground transportation options depending on regional availability. Patients can use the Suvoda App to book eligible rides and view important travel information, including flight details, hotel arrangements, rideshare status, clinical study appointments, questionnaires and payment information. Bringing these functions together within a single application is intended to reduce the need for repeated communication between patients and research site personnel. The enhanced system also provides clinical trial sites with improved travel request workflows, clearer trip-status visibility and secure messaging capabilities. These improvements can help research coordinators spend less time managing transportation arrangements and responding to routine travel-related enquiries. Sponsors and CROs also gain access to more detailed reporting, providing greater visibility into travel expenses, trip progress and policy management across clinical research programmes. By connecting transportation services with clinical trial management activities, Suvoda aims to create a more convenient and coordinated experience for patients and research teams.
Flexible Travel Support Strengthens Clinical Trial Retention
Greenphire Travel now offers two distinct service models, allowing sponsors and clinical research teams to select travel assistance according to the complexity of individual studies. The site-led model enables research sites to initiate routine travel requests directly through the platform, supporting simpler transportation requirements with greater operational control. For studies involving more complex travel arrangements, the Concierge model provides personalised coordination and dedicated patient support. Concierge coordinators located across more than 40 countries offer 24-hour assistance throughout the clinical trial journey, helping participants navigate travel requirements and related logistical challenges. This approach can be particularly valuable for oncology and rare disease studies, where participants may experience additional physical, geographical or practical difficulties when attending research visits. The company has also designed the service to minimise financial barriers associated with clinical trial participation. Eligible travel expenses are funded upfront by the study sponsor and managed through Suvoda, meaning patients, caregivers and participating research sites do not need to pay covered travel costs out of pocket. Removing upfront transportation expenses and simplifying travel arrangements may help reduce avoidable participation barriers and support better clinical trial retention.
Advertisement
Suvoda Strengthens Global Clinical Trial Technology Platform
The expanded Greenphire Travel capabilities represent another development in Suvoda’s broader strategy to connect clinical trial operations through integrated digital technologies. The company reports that its travel services have supported more than 8,400 clinical research sites across over 2,000 trials in more than 50 countries. By combining transportation management, patient payments, study appointments and participant-facing digital tools, Suvoda aims to improve coordination between patients, sponsors, CROs and research sites. Elizabeth Smith, Director of Product Management, Patient Experience at Suvoda, emphasised that clinical trial participants are often managing serious health conditions alongside the logistical demands of attending study visits. Will Wing, Director of Product at Suvoda, highlighted the importance of real-time travel information, consolidated reporting and flexible support models in addressing increasingly complex clinical research requirements. The latest platform enhancements reflect the growing importance of patient-centric clinical trial technology in modern pharmaceutical and biotechnology research. As clinical studies become increasingly global and complex, digital solutions that simplify participant experiences may contribute to improved study accessibility and operational efficiency. Suvoda’s expanded Greenphire Travel platform aims to make clinical trial participation more manageable by giving patients greater transportation choice, reducing administrative workloads and strengthening travel support across international research programmes.
Source: Suvoda press release
